In summary, our data define additional CXCR4/CD5 subpopulations of divergent ages, phenotypes, and sensitivities to BTK inhibition, suggesting that CLL B-cell kinetics are more complex than the current model describes. This evidence concerns the gene CXCR4 and B-cell chronic lymphocytic leukemia.